학술논문

lncRNA ZEB1-AS1 promotes migration and metastasis of bladder cancer cells by post-transcriptional activation of ZEB1
Document Type
Academic Journal
Source
International Journal of Molecular Medicine. July 2019, Vol. 44 Issue 1, p196, 11 p.
Subject
United States
Japan
Germany
China
Language
English
ISSN
1107-3756
Abstract
Introduction Bladder cancer (Bca) is the most common malignancy of the urinary system in china (1) and worldwide (2), and is the primary cause of mortality in patients with urinary [...]
The prognosis for patients with metastatic bladder cancer (Bca) is poor, and has not been improved by current treatment methods. Long noncoding RNAs (lncRNAs) are involved in the pathology of various tumors, including bladder cancer. However, the role of zinc finger E-box-binding homeobox 1-antisense 1 (ZEB1-AS1) in BCa progression and metastasis remains unclear. The present study determined the expression level of ZEB1-AS1 in BCa and additionally investigated the functional role of ZEB1-AS1 in BCa metastasis. Reverse transcription quantitative polymerase chain reaction analysis showed that ZEB1-AS1 was upregulated in BCa cells compared with normal epithelial cells. Functionally, knockdown of ZEB1-AS1 suppressed BCa cell migration and invasion in vitro, and metastasis in vivo. Mechanistic investigations revealed that ZEB1-AS1 bound to heterogenous nuclear ribonucleoprotein d0 (AUF1), thereby activating the translation of ZEB1 mRNA without affecting its mRNA level. In addition, ZEB1-AS1 was significantly upregulated in BCa tissues and muscle-invasive Bca cases. ROc curve analysis demonstrated that ZEB1-AS1 expression was associated with metastasis in patients with Bca. In conclusion, the data from the present study demonstrated that ZEB1-AS1 induced BCa metastasis via an AUF1-mediated translation activation of ZEB1 mRNA mechanism. ZEB1-AS1 may serve as a promising target for clinical intervention in advanced Bca.